GET /api/v0.1/hansard/entries/1230841/?format=api
HTTP 200 OK
Allow: GET, PUT, PATCH, DELETE, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept

{
    "id": 1230841,
    "url": "https://info.mzalendo.com/api/v0.1/hansard/entries/1230841/?format=api",
    "text_counter": 426,
    "type": "speech",
    "speaker_name": "Endebess, UDA",
    "speaker_title": "Hon. (Dr.) Robert Pukose",
    "speaker": null,
    "content": " Thank you, Hon. Temporary Speaker. I thank the Members who have contributed. More so, I thank the Members of the Departmental Committee on Health for the time they have spent to make sure that they did public participation and went through the Treaty. If you read the Report, you will find that it captures issues about the Kenya Drugs Authority. If Members have time to go through the Report, they will realise that the AMA Treaty is key to us as a country. It makes sure we provide an enabling environment for pharmaceutical companies to manufacture drugs here. We have Moderna setting up a vaccine factory in Nairobi as we speak. We also have our Kenya Biovax Institute Limited (KBI) that will be producing vaccines soon. Once we start producing those medicines and vaccines, we should be able to sell and market them within the African Continent and even beyond. This means we are moving to a certain level. We will also be exposed to move into maturity level three. The electronic version of the Official Hansard Report is for information purposesonly. A certified version of this Report can be obtained from the Hansard Editor."
}